WHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from Omicron

Home / News / WHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from Omicron


https://www.thenationalnews.com/coronavirus/2022/01/04/vaccines-like-sinopharm-sinovac-protect-against-severe-hospitalisation-from-omicron-who/



            
                
                                            Recent NewsPfizer gives up on Paxlovid in less vulnerable COVID patients after data fail to impress.
it’s ‘high time’ that authorities revise definition of ‘fully vaccinated’: experts
Monkeypox outbreak won’t be the next global pandemic thanks to vaccines, drugs: analysts
GlaxoSmithKline’s sales soar thanks to Shingrix, COVID-19 antibody but oncology lags
Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: report
			
	
		
	



	
		About Us
	
	
		
	



	
		In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.

In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

	



	
	Read More


        

        
                    
                
                    Related Health Education
                                        
                        
                            
                                
                                    it’s ‘high time’ that authorities revise definition of ‘fully vaccinated’: experts                                
                            
                        
                                        
                        
                            
                                
                                    Monkeypox outbreak won’t be the next global pandemic thanks to vaccines, drugs: analysts                                
                            
                        
                                        
                        
                            
                                
                                    GlaxoSmithKline’s sales soar thanks to Shingrix, COVID-19 antibody but oncology lags                                
                            
                        
                                        
                        
                            
                                
                                    Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: report                                
                            
                        
                                        
                        
                            
                                
                                    Pfizer antiviral usage is ticking up in the US as uptake of Merck, AZ drugs remains limited

Related Posts

WHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from Omicron

Related Health Education